AST SpaceMobile vs. Boeing: Which Technology Stock Is a Better Buy in 2026?

The article frames a 2026 portfolio choice between AST SpaceMobile (ASTS) and Boeing (BA), citing ASTS FY2025 revenue near $70.9M (+1,505.2% YoY) versus a ~$341.9M net loss (net margin ~-482.2%) and negative free cash flow near -$1.1B. Boeing returned to profitability in FY2025 with revenue of nearly $89.5B (+34.5% YoY) and net income around $2.2B (net margin ~2.5%), though free cash flow was still negative at nearly -$1.9B. Valuation is presented as ASTS forward P/E 65.7x vs BA 52.8x (sector ~36.4x) alongside higher balance-sheet leverage for BA (debt-to-equity ~10.0x vs ASTS ~1.2x), leading to an overall mixed risk/return outlook.

Analysis

The market should treat this as a balance-sheet and execution spread, not a pure growth-versus-value debate. BA’s setup is only durable if it converts accounting profits into consistent free cash flow; otherwise the equity remains a highly levered claim on operational discipline, and any production hiccup will compress the multiple quickly. The Spirit integration helps control quality, but it also internalizes more execution risk and capital intensity, which means supplier leverage shifts from SPR to BA rather than disappearing.

ASTS is still a financing story disguised as a connectivity story. Definitive partner agreements matter less than the funding path needed to get from promise to deployable capacity; that makes dilution, delayed launches, and regulatory slippage the real near-term catalysts over the next 1-3 quarters. The second-order loser is SATS, which faces a higher bar for its own direct-to-device narrative if ASTS proves even partially viable; the potential winner is T if coverage expansion can lift retention without major capex, but that benefit is slower and harder to underwrite.

Contrarian view: the consensus may be overpaying for ASTS optionality while underestimating how fragile BA’s recovery is. Over 6-18 months, BA can compound from a repaired supply chain only if FCF turns positive and leverage declines; ASTS can rerate violently, but mostly on financing/newsflow rather than operating economics. The cleaner trade is not to bet on absolute winners, but to own the asset with visible cash conversion and fade the one that needs the capital markets to keep the story alive.

Key Decisions for Investors

• Long BA on pullbacks as a 6-12 month recovery trade; target only if free cash flow trends toward breakeven and leverage starts to fall, otherwise the thesis is false.
• Avoid chasing ASTS on partner-agreement headlines; consider a small tactical short or put-spread only if the stock rallies without new financing or launch milestones, with dilution/regulatory delay as the main catalyst.
• Pair trade: long BA / short ASTS for relative-value exposure to execution versus financing risk; keep size modest because ASTS can gap on binary news.
• Watch SATS as a second-order short only after ASTS secures durable funding and licensing; before that, the setup is too headline-driven to press.
• If BA fails to generate positive FCF in the next two reported quarters, cut exposure and reassess; if ASTS raises non-dilutive capital and advances launch cadence, cover any bearish position immediately.